RAPT Competitors & Alternatives
Compare RAPT Therapeutics Inc with similar stocks in the same industry
Biotechnology
RAPT
Main Stock$58.02
Tradestie Score
50
Market Cap
$450.49M
Revenue Growth
-1.0%
Analyst Upside
0.0%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.74
|
$1.78B | - | 37 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.20
|
$1.78B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.67
|
$1.77B | - | 32 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.40
|
$1.74B | - | 51 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.65
|
$1.68B | - | 60 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 50 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.40
|
$1.63B | - | 46 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.87
|
$1.57B | - | 50 | Compare |
|
VCEL
Vericel Corporation
|
$40.15
|
$1.56B | 83.9 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.21
|
$1.55B | - | 63 | Compare |
More RAPT Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry